Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

InfuSystems Holdings, Inc. Common Stock (NY: INFU )

4.970 -0.030 (-0.60%)
Official Closing Price Updated: 8:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,315
Open 4.950
Bid (Size) 4.460 (1)
Ask (Size) 5.390 (1)
Prev. Close 5.000
Today's Range 4.870 - 4.995
52wk Range 4.610 - 9.970
Shares Outstanding 20,568,489
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
InfuSystem Announces CEO Transition; Carrie Lachance to Become Chief Executive Officer
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
From InfuSystem Holdings, Inc.
Via Business Wire

Performance

YTD
-38.49%
-38.49%
1 Month
-17.72%
-17.72%
3 Month
-38.79%
-38.79%
6 Month
-23.89%
-23.89%
1 Year
-34.69%
-34.69%

More News

Read More
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
From InfuSystem Holdings, Inc.
Via Business Wire
Earnings Scheduled For March 4, 2025
Via Benzinga
Sidoti Events, LLC's Virtual December Small-Cap Conference
Via ACCESSWIRE
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Reports Third Quarter 2024 Financial Results
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
The Future of Medical Devices: Two Strong Buys You Can't Miss
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem to Participate in Lake Street’s 8th Annual Best Ideas Growth (BIG8) Conference September 12, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Reports Second Quarter 2024 Financial Results
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Announces Distribution Agreement with Smith+Nephew for Negative Pressure Wound Therapy System and First Shipment of NPWT Systems
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem to Report Second Quarter 2024 Financial Results on August 8, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Announces $20 Million Stock Repurchase Program
From InfuSystem Holdings, Inc.
Via Business Wire
INFU Stock Earnings: InfuSystems Holdings Misses EPS, Misses Revenue for Q1 2024
Via InvestorPlace
InfuSystem Reports First Quarter 2024 Financial Results
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem to Report First Quarter 2024 Financial Results on May 9, 2024
From InfuSystem Holdings, Inc.
Via Business Wire
InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K
From InfuSystem Holdings, Inc.
Via Business Wire
Double Down: 7 Beaten-Down Growth Stocks to Buy Hand Over Fist
Via InvestorPlace
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2023
From InfuSystem Holdings, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.